0001437749-23-002930.txt : 20230209
0001437749-23-002930.hdr.sgml : 20230209
20230209190106
ACCESSION NUMBER: 0001437749-23-002930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230207
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berard Todd
CENTRAL INDEX KEY: 0001633186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 23607915
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER NAME:
FORMER CONFORMED NAME: Beard Todd
DATE OF NAME CHANGE: 20150209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2023-02-07
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001633186
Berard Todd
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
Chief Marketing Officer
Common Stock
2023-02-07
4
M
0
1000
2.06
A
120265
D
Common Stock
2023-02-07
4
S
0
1000
25.29
D
119265
D
Common Stock
2023-02-08
4
M
0
9000
2.06
A
128265
D
Common Stock
2023-02-08
4
S
0
9000
25.13
D
119265
D
Stock Option (Right to Buy)
2.06
2023-02-07
4
M
0
1000
0
D
2016-05-04
2025-05-04
Common Stock
1000
39000
D
Stock Option (Right to Buy)
2.06
2023-02-08
4
M
0
9000
0
D
2016-05-04
2025-05-04
Common Stock
9000
30000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.25, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Exercisable to the extent of 1/4th thereof on 5/4/16, and remaining balance exercisable to the extent of 1/36th thereof on the 4th day of each month commencing on 6/4/16.
/s/ Todd C.J. Berard
2023-02-09